Damage to the retinal pigment epithelium (RPE) in age-related macular degeneration and other diseases results in photoreceptor cell death and blindness. Replacement of RPE is therefore being explored as a therapy for several retinal diseases. To move toward a future personalized autologous transplant approach, we have prepared a biocompatible implant using RPE derived from induced pluripotent stem cells (iPSCs) reprogrammed from a healthy donor's monocytes. The correct positioning of the polarized RPE is essential to fulfill its role and protect photoreceptors from degeneration. Hence, we have used a biocompatible hydrogel matrix of fibrin and agarose that allows the surgical placement of an RPE sheet in the subretinal space, keeping its fu...
Cell replacement therapy with induced pluripotent stem cells (iPSCs) is a promising treatment for di...
Stem cells, with their capacity to regenerate and replace diseased tissues, have recently been propo...
PurposeA subretinal implant termed CPCB-RPE1 is currently being developed to surgically replace dyst...
Purpose: Retinal pigment epithelial (RPE) cells are highly specialized neural cells with several fun...
Transplantation of the retinal pigment epithelium (RPE) is being developed as a cell-replacement the...
International audienceSeveral pathological conditions of the eye affect the functionality and/or the...
The review intends to overview a wide range of nanostructured natural, synthetic and biological memb...
Abstract Background Subretinal cell transplantation is a challenging surgical maneuver. This paper d...
BackgroundDysfunction of the retinal pigment epithelium (RPE) is implicated in numerous forms of ret...
The retinal pigment epithelium (RPE) is a multifunctional monolayer located at the back of the eye r...
One therapeutic approach for age-related macular degeneration (AMD) is the transplantation of pigmen...
The retina is a complex and fragile photosensitive part of the central nervous system which is prone...
SummaryTransplantation of the retinal pigment epithelium (RPE) is being developed as a cell-replacem...
Retinal pigment epithelium (RPE) transplantation for the treatment of macular degeneration has been ...
Age-related macular degeneration (AMD) is the leading cause of blindness in the western world, which...
Cell replacement therapy with induced pluripotent stem cells (iPSCs) is a promising treatment for di...
Stem cells, with their capacity to regenerate and replace diseased tissues, have recently been propo...
PurposeA subretinal implant termed CPCB-RPE1 is currently being developed to surgically replace dyst...
Purpose: Retinal pigment epithelial (RPE) cells are highly specialized neural cells with several fun...
Transplantation of the retinal pigment epithelium (RPE) is being developed as a cell-replacement the...
International audienceSeveral pathological conditions of the eye affect the functionality and/or the...
The review intends to overview a wide range of nanostructured natural, synthetic and biological memb...
Abstract Background Subretinal cell transplantation is a challenging surgical maneuver. This paper d...
BackgroundDysfunction of the retinal pigment epithelium (RPE) is implicated in numerous forms of ret...
The retinal pigment epithelium (RPE) is a multifunctional monolayer located at the back of the eye r...
One therapeutic approach for age-related macular degeneration (AMD) is the transplantation of pigmen...
The retina is a complex and fragile photosensitive part of the central nervous system which is prone...
SummaryTransplantation of the retinal pigment epithelium (RPE) is being developed as a cell-replacem...
Retinal pigment epithelium (RPE) transplantation for the treatment of macular degeneration has been ...
Age-related macular degeneration (AMD) is the leading cause of blindness in the western world, which...
Cell replacement therapy with induced pluripotent stem cells (iPSCs) is a promising treatment for di...
Stem cells, with their capacity to regenerate and replace diseased tissues, have recently been propo...
PurposeA subretinal implant termed CPCB-RPE1 is currently being developed to surgically replace dyst...